Immuron Ltd balance sheet

At the end of fiscal 2026, Immuron Ltd had total assets of $9.1m, total liabilities of $1.4m and shareholders' equity of $7.7m. It held $6.2m in cash against $0 of debt: net cash of $6.2m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Immuron Ltd: balance sheet, annual
Fiscal year	2016Jun 2016	2017Jun 2017	2018Jun 2018	2019Jun 2019	2020Jun 2020	2021Jun 2021	2022Jun 2022	2023Jun 2023	2024Jun 2024	2025Jun 2025	2026Jun 2026
Cash and equivalents	2	3	3	4	2	19	15	11	8	2	6
Receivables	—	1	1	1	0	0	0	0	1	1	1
Inventory	—	2	0	0	1	0	0	1	1	1	2
Total current assets	—	6	5	5	3	19	16	14	10	7	9
Total assets	7	6	7	6	4	20	17	15	10	7	9
Total current liabilities	—	1	1	1	0	1	1	1	2	1	1
Short-term debt	—	0	—	—	—	—	—	—	—	—	—
Total debt	0	0	0	0	0	0	0	0	0	0	0
Total liabilities	3	1	1	1	0	1	1	2	2	1	1
Shareholders' equity	—	5	6	5	4	19	16	13	8	5	8
Net debt (negative = net cash)	−2	−3	−3	−4	−2	−19	−15	−11	−8	−2	−6
Shares outstanding	2m	2m	3m	—	—	—	—	—	—	—	—

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: IMRN vs IVA IMRN vs TSHA ANL vs IMRN

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Immuron Ltd's SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Immuron Ltd.